Skip to main content
Tech.euFundingExplorerBeta

Aurealis Pharma

Aurealis Pharma is a biopharmaceutical company.

Total raised
€6.7M
€6,708,000
Funding rounds
1
Investors
1
distinct backers
Active since
2018-12
latest 2018-12

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood18
base rate 48% for Series B
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2019-01-01Series B€6.7MFinnvera Venture CapitalView deal →

Related news

Similar companies

same sector or country